NOVEL NANOPARTICLE TECHNOLOGY

As the Bioabsorbable Nanoparticle Technology segment, Nomisma Healthcare is primarily focused on developing innovative PLGA, PLA, and PGA -based products to address specific medical challenges that are not resolved by current technology or drug products.

MORE THAN POLYMERS

Nomisma Healthcare has a long history of creating the highest purity Bioabsorsable Polymers available. Our passion for high-quality and unique products is only exceeded by our excellent reputation in the marketplace.

COMPLIANCE TO GMP

Nomisma establishes a Development Team to ensure the development of the smooth polymer you need. Our experienced organic chemists will oversee the process development and scale-up while our Polymer analysts guarantee that Nomisma quality prevails at each step.

OUR EXPERTISE

 

COMPLIANCE


Nomisma Healthcare is a manufacturer and supplier of bioresorbable polymers for Parenteral Controlled Release Drug Delivery Systems & Medical Devices, which are highly pure and compliant with FDA Guidance.

EXPERT STAFF


More than 25 years of experience in the field of polymer chemistry & Pharmaceutical chemistry. Good knowledge of cGMP, 21 CFR, and Other regulatory aspects

FAST DELIVERY TIME


Dispatching the consignment within 2 to 4 weeks after the order is confirmed.

For Regular products, Next day delivery.

RAISE QUALITY STANDARDS


Through the knowledge and applicability – our people, products, and services to customers across the globe – Nomisma continues to expand its services with renewable and sustainable solutions.

WALK-IN'S ACCEPTED


We are the world’s polymer supplier to support pharmaceutical and medical applications for which projects can be well established with minimal effect in the project economy when polymer usage is considered as one of the ingredients.

LOW TIN METAL LEVEL


All bioresorbable polymers meet typical drug and device regulatory thresholds for tin metal levels established by health authorities with significantly lower tin metal levels than regulatory requirements.

POPULAR PRODUCTS


 

DLG554G | PLGA 55:45

DLG554G | PLGA 55:45 star Glucose is a Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 55:45 molar ratio having an inherent viscosity midpoint of 0.45 dl/g. It is supplied in the form of white to light tan micronized powder. DLG554G | PLGA 55:45 is primarily used for the Octreotide Depot microsphere and other drug delivery applications.

 

DLG 75-6P | PLGA 75:25

DLG75-6P is a PEG terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.6 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-6P is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG 75-9E | PLGA 75:25

DLG75-9E is an Ester terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.9 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-9E is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG 75-7E | PLGA 75:25

DLG75-7E is an Ester terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.7 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-7E is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG 75-2E | PLGA 75:25

DLG75-2E is an Ester terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.2 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-2E is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG 75-8A | PLGA 75:25

DLG 75-8A is an acid terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.8 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-8A is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques and Medical implants.

 

DLG 75-7A | PLGA 75:25

DLG75-7A is an acid terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.7 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-57 is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG 75-5A | PLGA 75:25

DLG75-5A is an acid terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.5 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-5A is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG 75-10A | PLGA 75:25

DLG 75-10A is an acid terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 1.0 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-10A is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques and Medical implants.

 

DLG 75-4A | PLGA 75:25

DLG75-4A is an acid terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.4 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-4A is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

DLG75-2A | PLGA 75:25

DLG75-2A is an acid terminated Pharma / Medical Grade copolymer of DL-lactide and Glycolide in a 75:25 molar ratio and with an inherent viscosity midpoint of 0.2 dl/g. It is supplied in the form of white to light tan micronized powder. DLG75-2A is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

 

The hydrogel polymer is an application-tailored PLGA-PEG-PLGA triblock polymer

The hydrogel polymer is an application-tailored PLGA-PEG-PLGA triblock polymer

The hydrogel polymer is an application-tailored PLGA-PEG-PLGA triblock polymer.
The polymer molecule exhibits a hydrophilic core region and hydrophilic ends. An aqueous solution of this polymer is reverse thermosensitive, meaning it is fluid and injectable at room temperature and will rapidly form a hydrogel at body temperature (e.g. after subcutaneous injection).

Dissolution of PLGA

Dissolution of PLGA

Dissolution of PLGA in different solvents depending on the L: G ratio. The PLGA dissolution depends on the polymer concentration, polymer molecular...

Application : Drug Delivery

Application : Drug Delivery

Formulation developers are using self-absorbable polymers to create drug delivery systems that improve the patient’s health. Flexibility,...

Pioneer in Bioabsorbable polymers

Pioneer in Bioabsorbable polymers

Nomisma Healthcare is one of the world’s leading specialty polymers manufacturer and supplier companies. Serving customers in consumer and...